Ingredients

Fisetin Dosage: Research Summary & Clinical Doses Used

Written by ReCellence™ Editorial Team, Health Content SpecialistsReviewed by Medical Review Board, MD, PhDLast reviewed: March 7, 2026

Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.

What This Page Explains

There is no established recommended dosage for fisetin. Unlike pharmaceutical drugs that undergo Phase III dose-finding trials, fisetin dosing in research has been exploratory and varies significantly between studies. This page summarizes the doses that have been used in published and registered human clinical trials.

Still Think Energy Drinks Are the Answer?

Caffeine and sugar don't fix broken mitochondria. They mask the problem while the damage compounds. Here's what actually works at the cellular level.

Detailed Evidence

The most commonly studied dosing protocol uses approximately 20 mg/kg/day. For a 70 kg (154 lb) adult, this equates to approximately 1400 mg per day, typically administered for 2 consecutive days, followed by 28 days off — a pattern known as 'hit-and-run' or intermittent senolytic dosing.

Evidence Hierarchy

Strongest

Systematic Reviews & Meta-Analyses

Multiple high-quality trials combined

Strong

Randomized Controlled Trials (RCTs)

Gold standard for treatment efficacy

Moderate

Observational Studies

Can show associations, not causation

Limited

Case Reports & Expert Opinion

Hypothesis-generating only

Weakest

Preclinical (Lab/Animal) Studies

Should NOT be extrapolated to humans

The Research Is In. The Solution Exists. The Only Question Is: Will You Act?

You've read the science. You understand the mechanisms. Now it's time to apply that knowledge to your own cellular health.

Study Quality Indicators

Higher Quality Indicators

  • Large sample size (hundreds to thousands)
  • Randomized and blinded design
  • Placebo-controlled comparison
  • Published in peer-reviewed journals
  • Replicated in multiple studies
  • Registered trial protocol before starting

Lower Quality Indicators

  • Small sample size (under 100)
  • No control group or blinding
  • Manufacturer-funded with conflicts
  • Only animal/cell studies
  • Never replicated
  • Published in predatory journals

Important Limitations

  • • Supplement research often has methodological limitations
  • • Results from one study may not generalize to all people
  • • Marketing claims often exceed what research supports
  • • Absence of evidence is not evidence of absence
  • • Individual response to supplements varies widely

Quick Answers

Q1.

What dose of fisetin should I take?

There is no established recommended dosage. Clinical trials have used approximately 20 mg/kg/day (roughly 1400 mg for a 70 kg adult) for 2 consecutive days in intermittent protocols. Consult a qualified healthcare provider.

Q2.

How often should you take fisetin?

Clinical trials have used intermittent 'hit-and-run' protocols: 2 consecutive days of dosing, followed by 28 days off. This is based on the hypothesis that brief high-dose exposure is sufficient to trigger apoptosis in senescent cells.

Q3.

What is intermittent senolytic dosing?

Intermittent senolytic dosing involves brief, high-dose exposure (e.g., 2 consecutive days) followed by a recovery period (e.g., 28 days off). The theory is that this is sufficient to clear senescent cells, followed by debris clearance and new cell generation.

Q4.

Is 100 mg of fisetin enough?

OTC supplements typically contain 100–500 mg per capsule — substantially lower than clinical trial doses of 1400+ mg. It is unclear whether daily low-dose supplementation achieves the same biological effects as intermittent high-dose protocols.

Q5.

Can I take fisetin every day?

Daily continuous dosing and intermittent senolytic dosing represent fundamentally different biological rationales that have never been compared head-to-head in clinical trials.

Q6.

How much fisetin per kg body weight?

Clinical senolytic trials use fisetin at approximately 20 mg/kg/day. This means individual doses range from ~1000 mg (50 kg adult) to ~2000 mg (100 kg adult) within the same protocol.

Q7.

Should fisetin be taken with food?

Mild GI discomfort may occur at higher doses and typically resolves with food. However, specific food-effect studies on fisetin absorption have not been published.

Q8.

Can I combine fisetin with quercetin?

Research suggests fisetin and quercetin may be synergistic — fisetin handles senescent cell clearance while quercetin builds antioxidant defenses. However, combination protocols have not been rigorously studied in human trials.

Q9.

Is there a maximum dose of fisetin?

No regulatory body has established a maximum dose or upper intake level (UL) for fisetin. Acute toxicity studies indicate a wide safety margin, but long-term high-dose safety has not been characterized.

Q10.

What dose did the mouse study use?

The 2018 mouse study used 100 mg/kg/day for 5 consecutive days, which allometrically scales to approximately 500–800 mg/day in humans.

Key Research Facts

1

Clinical senolytic trials use fisetin at approximately 20 mg/kg/day — roughly 1400 mg for a 70 kg adult — administered for 2 consecutive days.

Strong Evidence

Verdoorn et al., JAGS / Kirkland & Tchkonia — doi:10.1111/jgs.17416

2

The intermittent 'hit-and-run' dosing protocol is based on the hypothesis that brief high-dose exposure is sufficient to trigger apoptosis in senescent cells.

Moderate Evidence

Kirkland & Tchkonia, J Internal Medicine — doi:10.1111/joim.13141

3

OTC fisetin supplements typically contain 100–500 mg per capsule — substantially lower than clinical trial doses of 1400+ mg.

Strong Evidence

Market survey — Supplement market analysis

4

No regulatory body has established a recommended dietary allowance (RDA) or upper intake level (UL) for fisetin.

Strong Evidence

FDA/EFSA regulatory status — Regulatory review

5

The 2018 mouse study used 100 mg/kg/day for 5 consecutive days, which allometrically scales to approximately 500–800 mg/day in humans.

Moderate Evidence

Yousefzadeh et al., EBioMedicine — doi:10.1016/j.ebiom.2018.09.015

6

The vascular function trial (NCT06133634) uses 20 mg/kg/day for 2 days per month over 3 months — the most rigorous dose-schedule design for fisetin.

Emerging Evidence

ClinicalTrials.gov — NCT06133634

7

Given fisetin's <10% oral bioavailability, the effective systemic dose from a 1400 mg oral dose may be less than 140 mg reaching circulation.

Moderate Evidence

Grynkiewicz & Demchuk, Frontiers in Chemistry — doi:10.3389/fchem.2019.00159

Citations & External Resources

Clinical Registry

ClinicalTrials.gov — Search: Fisetin

Review

EBioMedicine — Yousefzadeh et al. 2018 (Landmark Senolytic Study)

Review

JAGS — Verdoorn et al. 2021 (Dosing Protocol)

Review

Journal of Internal Medicine — Kirkland & Tchkonia 2020 (Senolytic Review)

What 3,247 PubMed Studies Say About Cellular Energy and Aging

The scientific consensus is clear: mitochondrial dysfunction drives age-related decline. Here's the compound protocol that addresses it.

Related Reading

References (3)

Written by

ReCellence™ Editorial Team

Health Content Specialists

Medically reviewed by

Medical Review Board

MD, PhD

Last updated: March 8, 2026

Last medical review: March 8, 2026